NEWS BRIEF
Computed tomography (CT) todayGE HealthCare has pioneered bold ideas in CT innovation for over 50 years, delivering advanced imaging solutions that help healthcare providers meet growing demands. Today’s CT systems integrate AI and workflow solutions to enhance efficiency and diagnostic confidence, enabling radiologists to detect subtle abnormalities quickly and accurately. As part of its commitment to improving global patient outcomes, GE HealthCare continues to intentionally innovate to create products that are guided by purpose with patients and clinicians at the forefront to solve clinical and operational challenges.
*NEW* Photonova™ Spectrai with Deep Silicon reimagines photon-counting CT
GE HealthCare announced the submission of a 510(k) to the U.S. FDA seeking clearance for Photonova™ Spectra,i its new photon-counting computed tomography (PCCT) system with advanced AI algorithmsii – marking a major milestone in the company’s decades-long history of CT innovation. With 8-bins of energy resolution and built on GE HealthCare’s proprietary Deep Silicon detector technology, Photonova Spectra is designed to deliver remarkable spectral and spatial resolution for ultra-high-definition (UHD) imaging with wide coverage, seeking to enable fast acquisition speeds, precise visualization of anatomical structures and enhanced material separation.
Photon counting CT represents a transformative advancement in medical imaging. Unlike conventional CT systems that convert X-rays into light before measuring them, photon counting CT directly counts individual X-ray photons and measures their energy, enabling the potential for higher spectral and spatial resolution and improved tissue characterization. This process makes it possible to give clinicians more information and confidence to help detect and diagnose disease. Photonova Spectra takes this innovation further by using Deep Silicon, a novel detector material that is designed to bring enhanced spectral imaging, aiming to support advanced lesion characterization and treatment monitoring with CT.
“Today marks a transformative leap for GE HealthCare and a bold new chapter in CT innovation. Photonova Spectra is more than a new product – it’s a demonstration of what’s possible when vision meets purposeful design,” says Peter Arduini, President & CEO of GE HealthCare. “By uniting intelligence, speed and precision, this new system aims to redefine how clinicians see, decide and deliver care. This is innovation with impact designed to reshape workflows, sharpen image quality and empower confident, timely decisions. I am immensely proud of our teams and collaborators who are transforming the future of CT and bringing precision care to life.”
In today’s fast-paced healthcare environment clinicians need definitive answers, especially as patient volumes riseiii and diagnostic complexity increases. GE HealthCare’s Photonova Spectra was intentionally engineered to address these challenges. Harnessing the full potential of its proprietary Deep Silicon detectors, the system’s UHD imaging is designed to deliver wide coverage, enabling fast acquisition speeds and the precise visualization of subtle tissue variations, small lesions and vascular structures. With on-demand spectral imaging for every scan, it also seeks to empower clinicians to detect, characterize and monitor disease with confidence. Staff can also rely on one protocol setup for many exams, reducing complexity and supporting efficiency. Altogether, these capabilities aim to deliver clinicians the information they need in one exam and enable fast, confident diagnoses and treatment planning.
View the full press release here.
Revolution™ Apex platform and Revolution™ Vibe
GE HealthCare continues to push the boundaries of CT innovation with new enhancements to its scalable Revolution™ Apex platformv, as well as Revolution™ Vibe, introducing AI-powered imaging tools, intelligent automation, and predictive analytics designed to streamline workflows and help reduce clinician burden.
Among the latest advancements, the 510(k) pending True Definition DLiv is designed to deliver crisp, high-resolution images with exceptional sharpness—aiming to support fast scan times and long scan ranges across pulmonary, musculoskeletal, and inner ear imaging. Available on the Revolution™ Apex platform and Revolution™ Vibe, this AI-driven technology is designed to elevate diagnostic confidence while seeking to overcome typical challenges of high-resolution imaging.
In cardiac imaging, GE HealthCare aims to redefine what’s possible with enhancements to the Effortless Workflow within its CT portfolio. Technologies aimed at simplifying complex procedures include Smart Phase, Snapshot Freeze, and CardIQ Suitevii all on AW Oneviii , as well as Cardiac Auto Viewsix . When added to the impressive Unlimited 1-beat cardiac and ECG-less capabilities on the Revolution Apex platform and Revolution Vibe system, these technologies may help clinicians achieve consistent, high-quality cardiac images quickly.
The CT ONE user experience has been developed based on insights from customers for an intuitive workflow, and aims to help simplify scan processes and may help reduce manual steps, enabling technologists to stay focused while working in dynamic clinical environments. For facilities focused on sustainability, Energy Saving Mode 3.0 helps reduce power consumption during off-hours—aligning imaging performance with environmental goals. To further support operational continuity, OnWatch Predict for CT uses predictive analytics to help minimize unplanned downtime on Apex systems.
These innovations reflect GE HealthCare’s commitment to empowering imaging teams with intelligent tools that enhance clinical precision, operational efficiency, and patient care.
AW ONE
The next evolution of GE HealthCare's AW platform, AW ONE supports a broad portfolio of AI-powered advanced visualization and post-processing applications across CT, MR, PET/CT, and interventional. From oncology to cardiology, AW ONE delivers seamless access to over 50 clinical applications that are designed to turn complex imaging data into actionable insights, enabling fast, confident decisions. The platform fits effortlessly into existing workflows and systems and supports flexible deployment and licensing options that can scale with clinicians’ needs from single sites to large hospital networks.
New applications on the AW ONE platform include VersaViewer™ with One View, CardIQ Suite v2, and SnapShot Freeze v3.
- VersaViewer™ with One View simplifies Spectral CT interpretation by automatically unifying multi-energy datasets into a single, AI-optimized view—eliminating the need to toggle between series or adjust contrast manually. With AI-driven segmentation tailored to each organx , it helps reduce cognitive load, and helps radiologists focus on confident, uninterrupted decision-making.
- CardIQ Suite v2 is an AI-powered cardiac CT post-processing solution that streamlines calcium scoring and CCTA interpretation. It features deep learning-based calcium scoring, percentile risk rankings, and heart fat volume estimation. AI-driven coronary analysis automates vessel segmentation and labels coronary arteries with high accuracy.
- SnapShot Freeze v3 takes whole-heart motion correction to the next level with a 6X reduction in motion artifactsix. This latest release now supports motion correction across multiphase acquisitions and adds compatibility with ultra high-resolution and spectral exams.
Margaret Steinhafel
Global Communications Director
Molecular Imaging & Computed Tomography
M: +1 608 381 8829
iPhotonova Spectra is 510(k)-pending with the U.S. FDA. Not CE Marked. Not available for sale in the United States, Europe, Canada, or any other region
iiEnhanced Boundary for PCCT is 510(k)-pending with the U.S. FDA. Not CE Marked. Not available for sale in the United States, Europe, Canada, or any other region.
iiiKaufman Hall. State of Hospital Volumes. Kaufman Hall, https://www.kaufmanhall.com/insights/infographic/state-hospital-volumes. Accessed October 6, 2025.
ivSittig, Dean F., and Hardeep Singh. A New Socio-technical Model for Studying Health Information Technology in Complex Adaptive Healthcare Systems. In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 1: Assessment). Rockville (MD): Agency for Healthcare Research and Quality (US); August 2008. https://www.ncbi.nlm.nih.gov/books/NBK338593/. Accessed October 6, 2025.
vRevolution Apex platform is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region.
vi510(k) Pending at the U.S. FDA. Not available for sale in the United States.
viiCardIQ Suite v2 requires AW Server 3.2 with Web Client.
viiiAW ONE combines AW Server hardware, software, and visualization applications.
ixEffective temporal resolution achieved by a 6x improvement of motion-blur reduction while maintaining high spatial resolution as demonstrated in cardiac phantom testing. The reduction in motion artifacts is comparable to a 0.039 Equivalent Gantry Rotation Speed with effective temporal resolution of 19.5 msec, as demonstrated in mechanical and mathematical phantom testing. Validated with version 3.
xCleared for Lung, Liver, Skeleton, Aorta and Body
iiEnhanced Boundary for PCCT is 510(k)-pending with the U.S. FDA. Not CE Marked. Not available for sale in the United States, Europe, Canada, or any other region.
iiiKaufman Hall. State of Hospital Volumes. Kaufman Hall, https://www.kaufmanhall.com/insights/infographic/state-hospital-volumes. Accessed October 6, 2025.
ivSittig, Dean F., and Hardeep Singh. A New Socio-technical Model for Studying Health Information Technology in Complex Adaptive Healthcare Systems. In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 1: Assessment). Rockville (MD): Agency for Healthcare Research and Quality (US); August 2008. https://www.ncbi.nlm.nih.gov/books/NBK338593/. Accessed October 6, 2025.
vRevolution Apex platform is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region.
vi510(k) Pending at the U.S. FDA. Not available for sale in the United States.
viiCardIQ Suite v2 requires AW Server 3.2 with Web Client.
viiiAW ONE combines AW Server hardware, software, and visualization applications.
ixEffective temporal resolution achieved by a 6x improvement of motion-blur reduction while maintaining high spatial resolution as demonstrated in cardiac phantom testing. The reduction in motion artifacts is comparable to a 0.039 Equivalent Gantry Rotation Speed with effective temporal resolution of 19.5 msec, as demonstrated in mechanical and mathematical phantom testing. Validated with version 3.
xCleared for Lung, Liver, Skeleton, Aorta and Body